We are live on ! Find out more
DFTX

Definium Therapeutics
DFTX

101 hedge funds and large institutions have $20.5M invested in Definium Therapeutics in 2022 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 34 increasing their positions, 34 reducing their positions, and 72 closing their positions.

New
Increased
Maintained
Reduced
Closed

240% more call options, than puts

Call options by funds: $20.9M | Put options by funds: $6.14M

100% more funds holding in top 10

Funds holding in top 10: 1 → 2 (+1)

37% more capital invested

Capital invested by funds: $14.9M → $20.5M (+$5.59M)

19.01% more ownership

Funds ownership: 0.36% → 19.37% (+19%)

0% more repeat investments, than reductions

Existing positions increased: 34 | Existing positions reduced: 34

35% less funds holding

Funds holding: 155 → 101 (-54)

75% less first-time investments, than exits

New positions opened: 18 | Existing positions closed: 72

Holders
101
Holders Change
-54
Holders Change %
-34.84%
% of All Funds
1.74%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
18
Increased
34
Reduced
34
Closed
72
Calls
$20.9M
Puts
$6.14M
Net Calls
+$14.7M
Net Calls Change
+$13.7M

Top Buyers

1
DCI
Data Collective IV
California
+$13.5M
2
MFG
Merit Financial Group
Georgia
+$10M
3
Alyeska Investment Group
Alyeska Investment Group
Illinois
+$9.6M
4
CH
CVI Holdings
Delaware
+$6.26M
5
EAM
Empery Asset Management
New York
+$1.8M

Top Sellers

1
Millennium Management
Millennium Management
New York
-$1.76M
2
E
Ergoteles
New York
-$696K
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$405K
4
LPL Financial
LPL Financial
California
-$324K
5
PCM
Penserra Capital Management
California
-$282K
Name Holding Trade Value Shares
Change 		Change in
Stake
LCM
76
Laurion Capital Management
New York
– -$85K -8,822 Closed
IC
77
Ikarian Capital
Texas
– -$68K -7,064 Closed
Parallax Volatility Advisers
78
Parallax Volatility Advisers
California
– -$64K -6,674 Closed
SC
79
Scotia Capital
Ontario, Canada
– -$58K -6,103 Closed
AGAM
80
Audent Global Asset Management
California
– -$50K -5,200 Closed
GG
81
Gofen & Glossberg
Illinois
– -$46K -4,833 Closed
Balyasny Asset Management
82
Balyasny Asset Management
Illinois
– -$42K -4,420 Closed
Creative Planning
83
Creative Planning
Kansas
– -$34K -3,544 Closed
QPW
84
Quantum Private Wealth
Florida
– -$28K -3,003 Closed
Bank of New York Mellon
85
Bank of New York Mellon
New York
– -$28K -2,853 Closed
Squarepoint
86
Squarepoint
New York
– -$27K -2,779 Closed
AWM
87
Accurate Wealth Management
Florida
– -$26K -2,683 Closed
JIP
88
Jaffetilchin Investment Partners
Florida
– -$24K -2,457 Closed
PAG
89
Private Advisor Group
New Jersey
– -$23K -2,404 Closed
WS
90
Wedbush Securities
California
– -$23K -2,400 Closed
TI
91
tru Independence
Oregon
– -$21K -2,153 Closed
HSBC Holdings
92
HSBC Holdings
United Kingdom
– -$20K -2,120 Closed
AGM
93
Alpine Global Management
New York
– -$20K -2,117 Closed
MMA
94
Miracle Mile Advisors
California
– -$19K -2,000 Closed
SB
95
Strategic Blueprint
Georgia
– -$18K -1,867 Closed
CAG
96
Crestwood Advisors Group
Massachusetts
– -$14K -1,467 Closed
GT
97
Glenmede Trust
Pennsylvania
– -$13K -1,439 Closed
KJHP
98
K.J. Harrison & Partners
Ontario, Canada
– -$14K -1,433 Closed
ICG
99
InterOcean Capital Group
Tennessee
– -$13K -1,334 Closed
Fisher Asset Management
100
Fisher Asset Management
Washington
– -$13K -1,333 Closed
2 3
4
5 6

DFTX Hedge Fund Activity: Q3 2022 in Review

101 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Definium Therapeutics (DFTX) for Q3 2022, worth a combined $20.5M — up 37% from $14.9M a quarter earlier.

Sellers outnumbered buyers: 72 funds closed out of DFTX and 18 opened new positions — a net loss of 54 holders — while 34 trimmed existing stakes and 34 added.

The largest buyer was Data Collective IV, adding an estimated $13.5M. The largest seller was Millennium Management, cutting an estimated $1.76M.

  • 101 institutional investors held Definium Therapeutics (DFTX) as of Q3 2022, down from 155 in Q2 2022.
  • Funds reported $20.5M of Definium Therapeutics stock for Q3 2022, up 37% quarter-over-quarter.
  • 18 funds opened new Definium Therapeutics positions in Q3 2022 and 72 closed out, a net change of -54 holders.
  • The largest Definium Therapeutics buyer in Q3 2022 was Data Collective IV, an estimated $13.5M added.
  • The largest Definium Therapeutics seller in Q3 2022 was Millennium Management, an estimated $1.76M sold.

Based on aggregated 13F filings for Q3 2022.